Research on pain-relieving drugs. Covers new pain-management startups, omega-3 approaches, drug safety, and AI-driven drug discovery.
A GSU study confirms that administering morphine prior to a painful procedure in infancy blocks long-term negative consequences of pain in adult rodents. Infant rodents who did not receive preemptive pain medication were less sensitive to morphine in adulthood, highlighting the need for pain relief in newborns.
Medication overuse headaches (MOH) are associated with severe disability and unmet treatment needs. Recent research suggests that treatments developed to prevent migraine may be effective in patients with MOH before withdrawal, pointing to the need for clinical trials to re-evaluate current strategies.
A novel nerve stimulator alleviates pain in patients with hemicrania continua, a rare form of chronic daily headache. The study found that five of six patients reported sufficient benefit to recommend the device.
Researchers discovered a new therapeutic target for pain control, identifying a protein that acts in pain-sensing neurons to convert chemical messengers into ones that suppress pain. The protein, PAP, is eight times more effective at suppressing pain than morphine and has longer-lasting effects.
A new study published in Pediatrics shows that implementing simple changes to hospital procedures can significantly reduce the harm caused by opiate use in children's hospitals. The study found that reducing prescription overrides and ensuring caregivers have up-to-date drug lists led to a 67% decrease in adverse events.
A recent study found that aspirin increases the expression of paraoxonase 1 and apolipoprotein A1, two proteins that help remove bad cholesterol from the bloodstream. This increase can lead to reduced risk of atherosclerosis, a condition characterized by the buildup of plaque in arteries.
A study published in The Lancet found that using paracetamol in the first year of life increases the risk of asthma, rhinoconjunctivitis, and eczema in children aged 6-7 years. The study analyzed data from over 200,000 children across 31 countries.
A new type of drug targets CB2 receptors to alleviate pain in human sensory nerves without affecting the brain. This research offers a promising alternative to opioids, which can have serious side effects such as dependency and nausea.
Common painkillers such as aspirin and ibuprofen appear to lower a man's PSA level, the blood biomarker used to gauge prostate cancer risk. However, the study does not prove a direct link between the medications and reduced risk of prostate cancer.
Regular NSAID use can reduce serum PSA levels, potentially altering prostate cancer detection in individuals taking these medications. Chronic inflammation linked to prostate cancer may be masked by NSAIDs, which inhibit COX enzymes.
A new study confirms Pycnogenol's effectiveness in reducing knee osteoarthritis symptoms, with a 20.9% improvement rate and significant reductions in pain and joint stiffness. After treatment cessation, the joints showed no relapse, suggesting a potential lasting effect on joint health.
A new study found that college freshmen believe occasional nonmedical use of prescription pain killers and stimulants is less risky than cocaine, but more risky than marijuana. Sensation-seekers are more likely to use these drugs nonmedically regardless of their perceived harm.
Patients with suboptimal response to aspirin and/or clopidogrel showed a significant reduction in myocardial damage during percutaneous coronary intervention when treated with tailored infusion of tirofiban. This treatment strategy aims to modulate intensity of treatment based on individual platelet reactivity.
A Phase II study found trends suggesting apixaban reduces heart attack, stroke risk but increases bleeding among higher doses, warranting further study.
The APPRAISE-I trial found a non-statistically significant trend that patients taking apixaban with aspirin or clopidogrel had lower incidence of heart attack, stroke, and cardiovascular death, compared to those taking a placebo. However, bleeding complications were a concern, especially at higher doses.
A randomized-controlled trial of 20,332 patients with ischaemic stroke found that anti-clotting regimens aspirin plus dipyridamole and clopidogrel showed no significant difference in reducing disability after recurrent stroke. Telmisartan, an angiotensin II receptor antagonist, also did not demonstrate neuroprotective effects.
A new guideline developed by the American Academy of Neurology recommends surgery as a treatment option for people with extreme face pain due to trigeminal neuralgia. The guideline suggests that patients who don't respond well to drugs should consider surgical interventions to target the root of the trigeminal nerve.
A U-M study finds that proton pump inhibitors (PPIs) are a cost-effective way to prevent upper GI bleeding in patients taking aspirin for cardiac events. Starting PPI therapy at age 50 or older is estimated to be highly cost-effective, while starting at younger ages may only be marginally so.
Researchers developed a predictive model using clinical data to identify individuals aged 40 and older who are at high risk of emergency hospital admissions. The model considers various factors such as age, gender, social deprivation, medication use, and previous hospitalizations.
A study examining anti-clotting therapy following cardioembolic stroke found that warfarin treatment appears to be safe and can begin at any point during hospital stay. In contrast, bridging with full doses of heparin or enoxaparin may carry high risk of intracranial and systemic bleeding.
USC School of Dentistry researchers found that aspirin can inhibit bone resorption and promote osteoblast formation in mice with osteoporosis. The study's findings suggest that aspirin may be a potential alternative to current treatments for osteoporosis, which affect both men and women.
A combination of sumatriptan and naproxen sodium taken within an hour of migraine onset significantly relieved symptoms in patients. The study, published in Neurology, showed that 50% of those who received the drug were pain-free after two hours, compared to 16% of those who took a placebo.
A study of newborn intensive care found that many painful procedures are performed without pain medication or therapy. Neonates experience high rates of repeated and prolonged pain exposure, which can alter their subsequent pain processing and behavior.
Researchers found that general anesthetics activate and sensitize specific receptors on neurons in the peripheral nervous system, increasing post-operative pain. The study suggests that this mechanism may be the reason why patients often experience increased discomfort after waking up from surgery.
A new study by Imperial College London found that people with IBS have a higher number of TRPV1 nerve fibers, which can cause abdominal pain and bloating. The study suggests that blocking this receptor could lead to new therapies for treating IBS symptoms.
Recent studies on pain medicine highlight the need for personalized treatment approaches. Researchers found that opioid therapy often lacks sufficient trial duration to determine its effectiveness for chronic pain sufferers.
A new study uses a graph-based approach to understand consumer preferences for over-the-counter pain relievers. The model identifies three distinct segments: price-conscious consumers, the athletic segment, and anti-medication users.
Researchers found NSAID use reduced Alzheimer's disease risk by 23% compared to non-users. The type of NSAID did not affect the risk reduction, challenging current theories about ibuprofen's benefits.
Lubiprostone has been shown to significantly improve all IBS-C symptoms in women, including abdominal pain, bloating, and constipation severity. The drug is also effective in treating IBS-C for up to one year, with improved stool consistency and reduced nausea and diarrhea.
A recent Australian study found that over 40% of parents have used cough medicine for children under 2 years old, despite warnings from health authorities. The most commonly used medication was paracetamol, and nearly half of parents gave their children anti-histamine-containing medications to treat colds.
The American Pain Society has expanded its low back guideline to include recommendations on surgery and interventional treatments for chronic pain. The new guidelines suggest that epidural stenosis injections may be an option for short-term pain relief, while other procedures have limited evidence supporting their benefits.
Research presented at the American Pain Society annual meeting found that less than 3% of patients with no history of drug abuse who are prescribed opioids for chronic pain will show signs of possible drug abuse or dependence. Most chronic pain patients do not rely on drugs as a sole solution, and multi-faceted treatment involving phys...
A study published in Neurology found that long-term use of ibuprofen and other NSAIDs was associated with a lower risk of Alzheimer's disease. The research analyzed data from over 49,000 veterans and showed that people who used ibuprofen for more than five years were 40% less likely to develop dementia.
A study published in The Lancet Neurology found that cilostazol is as effective as aspirin in preventing recurrent stroke, but causes fewer bleeding events. This suggests that cilostazol could be a more effective and safer alternative for Chinese patients with ischemic stroke.
A Princeton University survey found that 28% of Americans experience pain at any given moment, with those with less education and lower income spending more time in pain. The study also showed that pain can be a barrier to socializing, working, and overall well-being.
A study published in The Lancet found that nearly 30% of men and women reported feeling some level of pain at sampled times. People with lower incomes or less education spent more time in pain and had higher average pain ratings. Pain also imposes significant costs on the healthcare system, economy, and lost productivity.
Researchers found that daily aspirin use was associated with a small reduction in the risk of ER+ breast cancer, but not total breast cancer risk. Aspirin's irreversible effects on cyclooxygenase enzymes may disrupt breast cancer development by reducing estrogen production.
A hybrid technique combining dorsal column stimulator and peripheral nerve field stimulation effectively blocks body's pain signals, providing significant relief from chronic back and leg pain. The implantable procedure has shown promising results with patients experiencing 60-100% reduction in pain.
A new policy implemented in a Michigan clinic helped identify 35% of patients misusing opioid medications, while steering dependent patients to treatment. The approach logged and screened all patients receiving opioids for non-cancer pain, with the goal of protecting doctors' ability to prescribe these drugs.
A study by physiologists at Ball State University found that daily dosages of ibuprofen and acetaminophen increased quadriceps muscle mass and strength gained during three months of weight lifting. The findings suggest a positive effect on the metabolic response to resistance exercise, allowing for enhanced protein synthesis in muscle.
A new surgical technique, osteoprogenitor cellular grafting, has been used to treat steroid-induced osteonecrosis of the knee in three young patients. The procedure involves transplanting cellular material from the pelvic area into the knee, resulting in nearly normal activity and knee function with no complications.
A new study found that intensive antiplatelet therapy with prasugrel reduces ischemic events, including stent thrombosis, compared to standard clopidogrel. The treatment shows promise for patients undergoing percutaneous coronary intervention.
Researchers found that consumers with a relational processing mindset, which notices relationships between data, are shaped by context and can apply it to subsequent products. This contrasts with item-specific processing, where data is considered independently.
A study by Brown University scientists has found that activation of the pain receptor TRPV1 can trigger long-term depression, creating lasting changes in neural connections. This process is believed to be the cellular basis for memory making, with implications for drug development and potentially treating neural disorders.
A study published in the World Journal of Gastroenterology found that psychological intervention can effectively reduce post-embolization pain in patients undergoing hepatic arterial chemoembolization therapy. The research suggests that psychological intervention should be used as a complementary approach to pharmacological analgesia.
Researchers at the University at Buffalo found that taking ibuprofen while taking aspirin for stroke prevention reduces its effectiveness. In a study of 28 patients, all took ibuprofen and had no anti-platelet effect from their daily aspirin.
A new class of painkillers that block the TRPV1 receptor may interfere with brain functions such as learning and memory, according to a recent study. The researchers found that the receptor regulates neural mechanisms involved in establishing memory pathways in the brain.
A large study published in Thorax found that regular low-dose aspirin use cuts the risk of developing asthma among women by 10%. The Women's Health Study involved over 40,000 female healthcare professionals and monitored their health for around 10 years.
Researchers found that combining propofol and remifentanil with patient-controlled administration provides optimal pain relief while reducing staffing costs. This approach could help patients recover quicker and reduce healthcare expenses.
Patients receiving antiplatelet medications like aspirin after stroke show improved outcomes with clot-busting therapy. However, the study found a higher risk of brain hemorrhage in these patients, challenging existing guidelines.
A comprehensive review of 21 studies covering over 37,000 women found that anti-inflammatory drugs like aspirin may reduce breast cancer risk and provide a useful addition to treatment for existing sufferers
A provocative study by Dan Ariely found that a 10-cent pill is less effective at killing pain than a $2.50 pill, even when they are identical placebos. The study suggests that patients' subjective ratings of pain are influenced by the perceived quality and cost of medications.
A new study by Rush University Medical Center found that women are significantly less likely to be treated with statins, aspirin, and beta-blockers for coronary artery disease compared to men. Despite similar prevalence of adverse drug reactions, the study suggests underutilization of medical therapies may contribute to this disparity.
Researchers at the University at Buffalo found that up to 20% of patients taking aspirin for stroke and heart attack prevention do not respond to the medication, leading to increased risk of clinical failure. The study also identified factors associated with aspirin resistance, including younger age and underlying vascular disease.
Researchers present studies on the relationship between smoking and neuropathic pain, the benefits of physical conditioning in chronic pain patients, and the effectiveness of pain rehabilitation programs in reducing medication costs. These findings highlight the importance of addressing underlying causes of chronic pain and exploring n...
A study by Rush University Medical Center found that half of patients receiving cerebrovascular stents did not adequately respond to clopidogrel. The researchers identified a significant association between older age and diabetes with platelet activity, suggesting these patients may require alternative approaches.
Researchers demonstrated that microneedle patches can deliver clinically-relevant doses of drugs like naltrexone, reducing side effects and required dosage. The study also found lower production of metabolites, which may cause adverse reactions.
A new study published in Arthritis Care & Research found that taking two NSAIDs was associated with lower scores on a health-related quality of life assessment. Dual use was also linked to worse physical functioning and symptoms, highlighting the need for better pain management and patient communication.
Research with genetically modified mice shows that blocking a single cellular change can prevent morphine tolerance and dependence. The study suggests a new strategy to develop morphine derivatives with improved pain relief without addiction risk.
Researchers have restored the naked mole-rat's ability to feel pain, particularly in response to capsaicin, but remain insensitive to acids. This unique resistance may hold key to developing new pain relief strategies.